The Emirates Drug Establishment (EDE) announced that it has authorized Inpefa® (sotagliflozin), an innovative treatment for heart failure, making the UAE the second country worldwide to approve the therapy, in yet another step reflecting the UAE’s leadership in adopting pharmaceutical
